InsiderSignal.AI

InsiderSignal.ai

AKBA - Akebia Therapeutics, Inc.

Insider Purchase by Butler John P. (CEO, Pres)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Butler John P., serving as CEO, Pres at Akebia Therapeutics, Inc. (AKBA), purchased 69,270 shares at $1.25 per share, for a total transaction value of $86,588.00. Following this transaction, Butler John P. now holds 3,526,992 shares of AKBA.

This purchase represents a 2.00% increase in Butler John P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.

Akebia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Butler John P.

CEO, Pres

John P. Butler is the President, Chief Executive Officer, and Director of Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical company focused on developing and commercializing therapies for kidney disease patients. He joined Akebia in September 2013, leading its initial public offering in 2014, raising over $1 billion through equity offerings and license agreements, and orchestrating the 2018 merger with Keryx Biopharmaceuticals.[[1]](https://www.kidneyfund.org/profile/john-p-butler)[[3]](https://www.marketscreener.com/insider/JOHN-BUTLER-A07B68/) Butler brings over 35 years of experience in the biopharmaceutical industry, including prior roles as CEO of Inspiration Biopharmaceuticals (2011-2013), where he facilitated a major asset sale to Baxter; SVP and President of Cardiometabolic & Renal at Genzyme (2009-2011), launching products like Renagel®, Renvela®, and Hectorol®; and commercial leadership at Amgen for Epogen®. He has served on boards including Relypsa, Inc., Zynerba Pharmaceuticals, Keryx Biopharmaceuticals (as Chairman), and Wavebreak Therapeutics, and chaired Kidney Care Partners (2020-2023) and the American Kidney Fund board.[[1]](https://www.kidneyfund.org/profile/john-p-butler)[[2]](https://kidneycarepartners.org/press/john-p-butler-president-and-ceo-of-akebia-therapeutics-takes-helm-as-new-chair-of-nations-largest-kidney-coalition/)[[3]](https://www.marketscreener.com/insider/JOHN-BUTLER-A07B68/) Butler holds an undergraduate degree from Manhattan University and an MBA in Marketing Management from Baruch College (1994).[[3]](https://www.marketscreener.com/insider/JOHN-BUTLER-A07B68/)[[5]](https://www.bcaaalumni.org/index.php?option=com_content&view=article&id=54%3A2015-alumni-spotlight-john-butler&Itemid=144) As a corporate insider, he recently sold 144,250 shares of AKBA stock on February 3, 2025, under a Rule 10b5-1 plan, retaining over 2.6 million shares, and received significant equity awards in January 2026.[[4]](https://www.investing.com/news/insider-trading-news/akebia-therapeutics-ceo-john-butler-sells-302925-in-stock-93CH-3849253)[[6]](https://www.stocktitan.net/sec-filings/AKBA/form-4-akebia-therapeutics-inc-insider-trading-activity-9c6843ce185d.html)

View full insider profile →

Trade Price

$1.25

Quantity

69,270

Total Value

$86,588.00

Shares Owned

3,526,992

Trade Date

Wednesday, March 4, 2026

2 days ago

SEC Filing Date

Thursday, March 5, 2026

Filed 1 day after trade

HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

About Akebia Therapeutics, Inc.

Company Overview

No company information available
View news mentioning AKBA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4527251

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime